The UN General Assembly formally adopts the Modalities Resolution for the upcoming UN High-Level Meeting on TB, which sets out the dates, agenda, logistics, and other critical details for the meeting.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Advocates urge Cepheid to take immediate action necessary to bring about affordable, equitable, and expanded access to GeneXpert TB testing.

The World Health Organization releases an advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.

Roche‌ ‌announced the expansion of its collaboration with the U.S. Centers for Disease Control and Prevention (CDC) to strengthen laboratory capabilities in countries greatly affected by the HIV and TB epidemics. Through the implementation of a public-private partnership, named “Lab Networks for Health,” Roche and the CDC will seek to improve HIV and TB prevention, detection and treatment outcomes in select countries of Africa, Eastern Europe, Central Asia and the Western Hemisphere (e.g., Latin America, Central America and Caribbean regions).

Spotlight reflected on the results from two TB trials - SimpliciTB and TRUNCATE-TB, reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held on 19-22 February 2023 in Seattle, Washington, USA, featuring TAG TB Co-Director Lindsay McKenna, elaborating on what comes next as an alternative to the six-month drug-susceptible standard of TB care.

Treatment Action Group (TAG) released an overview of TB research data reported at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) held on 19-22 February 2023 in Seattle, Washington, USA. Highlights include the much-anticipated results of the SimpliciTB trial; additional analyses of the two-month TB treatment regimen studied in the TRUNCATE-TB trial; and the first clinical trial data on sutezolid since 2012.

Myanmar is the only country in the World Health Organization’s South-East Asia Region to achieve the 2020 deadline for the Sustainable Development Goals target of 20% reduction of TB incidence from the 2015 baseline. Collaboration of the public and private sectors has played an important role in the efforts to control TB. An increase in government spending on TB, newer diagnostic tools, use of mobile clinics, and making treatment affordable are some of the key elements of Myanmar’s approach to combat TB.

The United Nations General Assembly adopted a text, titled “Scope, modalities, format and organization of the high-level meeting on the fight against tuberculosis”, by which it decided that the one-day high-level meeting convened by its President shall be held at United Nations Headquarters in New York on 22 September 2023 during the general debate of the Assembly’s seventy-eighth session and shall consist of an opening segment, a plenary segment for general discussion, two multi-stakeholder panels and a brief closing segment. 

The SMART4TB Consortium is calling for expressions of interest from multi-national community advisory boards or similarly organized civil society organizations within three geographic focus areas (Eastern Europe and Central Asia; Africa; and South and Southeast Asia) to support community engagement in research in a new five-year research project funded by USAID: Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB).